AR | Androgen receptor | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
CPE | Carboxypeptidase E | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DENND4C | DENN/MADD domain containing 4C | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
EIF2AK3 | Eukaryotic translation initiation factor 2-alpha kinase 3 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
HNF1B | HNF1 homeobox B | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
HNF4A | Hepatocyte nuclear factor 4, alpha | Disease related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
PTPRN | Protein tyrosine phosphatase, receptor type, N | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
PTRF | Polymerase I and transcript release factor | Disease related genes Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
SLC2A2 | Solute carrier family 2 (facilitated glucose transporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
YWHAG | Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ADIPOQ | Adiponectin, C1Q and collagen domain containing | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
AHSG | Alpha-2-HS-glycoprotein | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
AKAP5 | A kinase (PRKA) anchor protein 5 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ANXA1 | Annexin A1 | Cancer-related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
ARNTL | Aryl hydrocarbon receptor nuclear translocator-like | Predicted intracellular proteins Predicted secreted proteins Transcription factors
| | | | | Expressed in all |
ATP6V0A1 | ATPase, H+ transporting, lysosomal V0 subunit a1 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP6V0A4 | ATPase, H+ transporting, lysosomal V0 subunit a4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ATP6V0D2 | ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2 | Predicted intracellular proteins
| | | | | Tissue enriched |
ATP6V1B1 | ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
ATP6V1B2 | ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2 | FDA approved drug targets Predicted intracellular proteins Transporters
| | | | | Expressed in all |
ATP6V1D | ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D | Predicted intracellular proteins
| | | | | Expressed in all |
ATP6V1E1 | ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1 | Plasma proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
ATP6V1F | ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F | Predicted intracellular proteins Transporters
| | | | | Expressed in all |
ATP6V1G2 | ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 | Predicted intracellular proteins
| | | | | Tissue enriched |
ATP6V1G3 | ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3 | Predicted intracellular proteins Transporters
| | | | | Tissue enriched |
ATP6V1H | ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H | Predicted intracellular proteins Transporters
| | | | | Expressed in all |
BAIAP2L1 | BAI1-associated protein 2-like 1 | Predicted intracellular proteins
| | | | | Mixed |
BCAR1 | Breast cancer anti-estrogen resistance 1 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
BDH1 | 3-hydroxybutyrate dehydrogenase, type 1 | Candidate cardiovascular disease genes Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Expressed in all |
BIRC5 | Baculoviral IAP repeat containing 5 | Cancer-related genes Predicted intracellular proteins
| | | | | Mixed |
CAB39 | Calcium binding protein 39 | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CACNA1A | Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
CASR | Calcium-sensing receptor | Disease related genes FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CD38 | CD38 molecule | Cancer-related genes CD markers Enzymes Predicted intracellular proteins
| | | | | Mixed |
CDK1 | Cyclin-dependent kinase 1 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
CDK16 | Cyclin-dependent kinase 16 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
CLOCK | Clock circadian regulator | Enzymes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
CPT1A | Carnitine palmitoyltransferase 1A (liver) | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CRY2 | Cryptochrome circadian clock 2 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
DOK2 | Docking protein 2, 56kDa | Predicted intracellular proteins
| | | | | Mixed |
DOK4 | Docking protein 4 | Predicted intracellular proteins
| | | | | Expressed in all |
EIF4E | Eukaryotic translation initiation factor 4E | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
FABP2 | Fatty acid binding protein 2, intestinal | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
FABP3 | Fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor) | Candidate cardiovascular disease genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
FETUB | Fetuin B | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
FGF1 | Fibroblast growth factor 1 (acidic) | Cancer-related genes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Group enriched |
FGFR3 | Fibroblast growth factor receptor 3 | Cancer-related genes CD markers Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
FRS3 | Fibroblast growth factor receptor substrate 3 | Predicted intracellular proteins
| | | | | Expressed in all |
GAD1 | Glutamate decarboxylase 1 (brain, 67kDa) | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
GJA1 | Gap junction protein, alpha 1, 43kDa | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Mixed |